Lack of association between complement factor H polymorphisms and coronary artery disease or myocardial infarction

Journal of Molecular Medicine

Volumn 85, Issue 7, 2007, Pages 771-775

  Nicaud, Viviane ^a,b   Francomme, Carole ^a,b   Ruidavets, Jean Bernard ^c   Luc, Gérald ^c   Arveiler, Dominique ^d   Kee, Frank ^e   Evans, Alun ^e   Morrison, Caroline ^f   Blankenberg, Stefan ^g   Cambien, François ^a,b   Tiret, Laurence ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f GLASGOW ROYAL INFIRMARY   (United Kingdom)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

CFH; CRP; Follow up; Myocardial infarction; Polymorphism

Indexed keywords

COMPLEMENT FACTOR H;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; COURSE EVALUATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SIMILARITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY;

EID: 34447322806     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0185-2     Document Type: Article

References (15)

1. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41:355-367
2. Oksjoki R, Jarva H, Kovanen PT, Laine P, Meri S, Pentikainen MO (2003) Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation. Arterioscler Thromb Vasc Biol 23:630-636
3. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385-389
4. Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K, Zhang K, Attia J (2006) Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 15:2784-2790
5. Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, Hofman A, Oostra BA, Van Duijn CM, de Jong PT, Witteman JC (2006) A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol 47:1568-1575
6. Zee RY, Diehl KA, Ridker PM (2006) Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study. Atherosclerosis 187:332-335
7. Goverdhan SV, Lotery AJ, Cree AJ, Ye S (2006) Complement factor H Y402H gene polymorphism in coronary artery disease and atherosclerosis. Atherosclerosis 188:213-214
8. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102:7227-7232
9. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, Schlumberger W, Meyer J (2001) Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104:25-31
10. Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet D, Barbaux S, Schnabel R, Bickel C, Espinola-Klein C, Poirier O, Perret C, Münzel T, Rupprecht HJ, Lackner K, Cambien F, Blankenberg S (2005) Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 112:643-650
11. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G et al (1992) A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 12:701-707
12. Kee F, Morrison C, Evans AE, McCrum E, McMaster D, Dallongeville J, Nicaud V, Poirier O, Cambien F (2000) Polymorphisms of the P-selectin gene and risk of myocardial infarction in men and women in the ECTIM extension study. Etude Cas-Témoin de l'Infarctus du Myocarde. Heart 84:548-552
13. Georges J, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, Ruidavets J, Cambien F, Tiret L (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM Study. J Mol Med 79:300-305
14. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL (2004) A new algorithm for haplotype-based association analysis: the stochastic-EM algorithm. Ann Hum Genet 68:165-177
15. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, Wade MS, Li Y, Liang L, Zareparsi S, Swaroop A, Abecasis GR (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38:1049-1054